Technology
Health
Biotechnology
Leap Therapeutics
$1.539876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$1.53
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.01 (0.99%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell LPTX and other stocks, options, ETFs, and crypto commission-free!
About
Leap Therapeutics, Inc. Common Stock, also called Leap Therapeutics, is a clinical stage biopharmaceutical company, which engages in developing novel therapies designed to treat patients with cancer. Read More Its clinical stage programs are DKN-01 and TRX518. The company was founded on January 3, 2011 and is headquartered in Cambridge, MA.
Employees
25
Headquarters
Cambridge, Massachusetts
Founded
2011
Market Cap
22.42M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
343.90K
High Today
$1.56
Low Today
$1.51
Open Price
$1.53
Volume
69.28K
52 Week High
$9.45
52 Week Low
$1.35
Collections
Technology
Health
Biotechnology
Medical
Therapy
Biopharmaceutical
Cancer Prevention
Pharmaceutical
Price Paid on Robinhood
34% Lower
Right Now
52 Week Low
$1.35
Average Price Paid
$2.30
52 Week High
$9.45
Earnings
-$0.85
-$0.70
-$0.56
-$0.41
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
-$0.41 per share
Actual
-$0.47 per share